Searchable abstracts of presentations at key conferences in endocrinology

ea0095p63 | Obesity 1 | BSPED2023

The positive effect of liraglutide treatment on body mass index and metabolic profile in adolescents with obesity

Atiq Elham , Apperley Louise , Parkinson Jennifer , Senniappan Senthil

Introduction: Obesity is a chronic and complex disease which is considered as one of the major health challenges with short- and long-term health consequences. Childhood obesity is defined as having a body mass index (BMI) at or above the 95th percentile for age and gender after two years of age. The glucagon-like peptide-1 (GLP-1) receptor agonist, liraglutide, is proven to promote weight reduction when used at a higher dose of 3.0 mg once daily. This study a...

ea0095p82 | Adrenal 2 | BSPED2023

Cortisol measurement using immunoassay versus liquid chromatography–tandem mass spectrometry in infants with congenital adrenal hyperplasia

Elham Atiq , Laura Walker , Senthil Senniappan , Joanne Blair

Introduction: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders that arise from enzyme deficiencies in biosynthetic pathways of the adrenal. The most common enzyme deficiency, 21-hydroxylase deficiency, results in cortisol deficiency, androgen excess and variable aldosterone deficiency. Current guidelines recommend a standard dose short Synacthen test (SDSST) is performed between 24 and 48 hours of life, with measurement of corti...